• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于高通量筛选的化合物库优化加权指数的开发。

The Development of a Weighted Index to Optimise Compound Libraries for High Throughput Screening.

机构信息

Chemical Biology, Chulabhorn Graduate Institute, 54 Kamphaeng Phet 6 Road, Talat Bang Khen sub-district, Lak Si district, Bangkok, 10210, Thailand.

School of Chemical Sciences, University of Auckland Private Bag 92019, Auckland, 1142, New Zealand.

出版信息

Mol Inform. 2019 Mar;38(3):e1800068. doi: 10.1002/minf.201800068. Epub 2018 Oct 22.

DOI:10.1002/minf.201800068
PMID:30345657
Abstract

1880 known drugs were collected and analysed for their mainstream molecular descriptors: MW, log P, HA, HD, RB and PSA. The statistical distributions were fitted to Gaussian functions for each of the descriptors. This gave a mathematical tool to calculate a weighted score, or an Index, for each descriptor. Known Drug Indexes (KDIs) were derived either by summation or multiplication of the Indexes, giving one number for each molecule calculated. The KDI summation and multiplication methods give a theoretical maxima of 6 and 1 respectively. According to both methods, methysergide (5.89/0.90), amsacrine (5.89/0.89) and fluorometholone (5.88/0.88) have the scores of the most well-balanced pharmaceuticals. The KDIs are advantageous tools in identifying the most well-balanced screening compounds based on the properties of known drugs; the screening collection can be optimised to only include quality compounds, which in turn produce tractable hit and lead compounds from the screening campaign.

摘要

收集了 1880 种已知药物,并对其主流分子描述符进行了分析:MW、log P、HA、HD、RB 和 PSA。为每个描述符的统计分布拟合了高斯函数。这为计算每个描述符的加权分数(或指数)提供了一个数学工具。通过对指数进行求和或相乘,可以得到已知药物指数(KDIs),从而为每个计算的分子生成一个数字。KDI 求和法和乘法法的理论最大值分别为 6 和 1。根据这两种方法,麦角乙脲(5.89/0.90)、安吖啶(5.89/0.89)和氟米龙(5.88/0.88)具有最平衡药物的评分。KDIs 是根据已知药物的特性识别最平衡筛选化合物的有利工具;筛选集可以优化为仅包含优质化合物,这反过来又可以从筛选活动中产生易于处理的命中和先导化合物。

相似文献

1
The Development of a Weighted Index to Optimise Compound Libraries for High Throughput Screening.一种用于高通量筛选的化合物库优化加权指数的开发。
Mol Inform. 2019 Mar;38(3):e1800068. doi: 10.1002/minf.201800068. Epub 2018 Oct 22.
2
QSAR modeling of imbalanced high-throughput screening data in PubChem.基于PubChem中不平衡高通量筛选数据的定量构效关系建模
J Chem Inf Model. 2014 Mar 24;54(3):705-12. doi: 10.1021/ci400737s. Epub 2014 Feb 28.
3
Biodiversity of small molecules--a new perspective in screening set selection.小分子的生物多样性——筛选集选择的新视角。
Drug Discov Today. 2013 Jul;18(13-14):674-80. doi: 10.1016/j.drudis.2013.02.005. Epub 2013 Feb 20.
4
Pharmaceutical Machine Learning: Virtual High-Throughput Screens Identifying Promising and Economical Small Molecule Inhibitors of Complement Factor C1s.药物机器学习:虚拟高通量筛选鉴定有前景且经济的补体因子 C1s 小分子抑制剂。
Biomolecules. 2018 May 7;8(2):24. doi: 10.3390/biom8020024.
5
Hit-to-Lead: Hit Validation and Assessment.从活性分子到先导化合物:活性分子验证与评估
Methods Enzymol. 2018;610:265-309. doi: 10.1016/bs.mie.2018.09.022. Epub 2018 Oct 25.
6
Locating sweet spots for screening hits and evaluating pan-assay interference filters from the performance analysis of two lead-like libraries.从两个类先导化合物库的性能分析中定位筛选命中的最佳点和评估通用分析干扰滤光片。
J Chem Inf Model. 2013 Mar 25;53(3):534-44. doi: 10.1021/ci300382f. Epub 2013 Mar 4.
7
PAIN(S) relievers for medicinal chemists: how computational methods can assist in hit evaluation.药物化学家的止痛剂:计算方法如何辅助活性筛选评估
Future Med Chem. 2018 Jul 1;10(13):1533-1535. doi: 10.4155/fmc-2018-0116. Epub 2018 Jun 29.
8
Cheminformatics approaches to analyze diversity in compound screening libraries.化学信息学方法分析化合物筛选库中的多样性。
Curr Opin Chem Biol. 2010 Jun;14(3):325-30. doi: 10.1016/j.cbpa.2010.03.017. Epub 2010 Apr 22.
9
Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files.基于平板的多样性子集筛选第二代:用于高通量筛选大型化合物文件的改进范式。
Mol Divers. 2016 Nov;20(4):789-803. doi: 10.1007/s11030-016-9692-9. Epub 2016 Sep 8.
10
Data-driven approaches used for compound library design, hit triage and bioactivity modeling in high-throughput screening.用于高通量筛选中化合物库设计、命中筛选和生物活性建模的数据驱动方法。
Brief Bioinform. 2018 Mar 1;19(2):277-285. doi: 10.1093/bib/bbw105.

引用本文的文献

1
New Dual Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 and 2 Based on Deoxycholic Acid: Design, Synthesis, Cytotoxicity, and Molecular Modeling.新型基于脱氧胆酸的酪氨酸-DNA 磷酸二酯酶 1 和 2 双重抑制剂:设计、合成、细胞毒性和分子模拟。
Molecules. 2024 Jan 24;29(3):581. doi: 10.3390/molecules29030581.
2
Indolo[2,3-]benzazocines and indolo[2,3-]benzazonines and their copper(II) complexes as microtubule destabilizing agents.吲哚并[2,3-]苯并氮杂卓和吲哚并[2,3-]苯并氮杂嗪及其铜(II)配合物作为微管去稳定剂。
Dalton Trans. 2023 Jul 25;52(29):9964-9982. doi: 10.1039/d3dt01632c.
3
New 5-Hydroxycoumarin-Based Tyrosyl-DNA Phosphodiesterase I Inhibitors Sensitize Tumor Cell Line to Topotecan.
基于新型 5-羟基香豆素的酪氨酰 DNA 磷酸二酯酶 I 抑制剂增敏肿瘤细胞系对拓扑替康的敏感性。
Int J Mol Sci. 2023 May 23;24(11):9155. doi: 10.3390/ijms24119155.
4
Discovery of New States of Immunomodulation for Vaccine Adjuvants via High Throughput Screening: Expanding Innate Responses to PRRs.通过高通量筛选发现疫苗佐剂免疫调节的新状态:扩展对模式识别受体的固有反应
ACS Cent Sci. 2023 Feb 23;9(3):427-439. doi: 10.1021/acscentsci.2c01351. eCollection 2023 Mar 22.
5
Novel TDP1 Inhibitors: Disubstituted Thiazolidine-2,4-Diones Containing Monoterpene Moieties.新型 TDP1 抑制剂:含单萜部分的二取代噻唑烷-2,4-二酮。
Int J Mol Sci. 2023 Feb 14;24(4):3834. doi: 10.3390/ijms24043834.
6
New Myrtenal-Adamantane Conjugates Alleviate Alzheimer's-Type Dementia in Rat Model.新型桃金娘烯醇-金刚烷缀合物可改善大鼠阿尔茨海默病样痴呆。
Molecules. 2022 Aug 25;27(17):5456. doi: 10.3390/molecules27175456.
7
Adamantane-Monoterpenoid Conjugates Linked via Heterocyclic Linkers Enhance the Cytotoxic Effect of Topotecan.通过杂环连接子连接的金刚烷-单萜化合物增强拓扑替康的细胞毒性作用。
Molecules. 2022 May 24;27(11):3374. doi: 10.3390/molecules27113374.
8
Discovery and Characterization of a Cryptic Secondary Binding Site in the Molecular Chaperone HSP70.发现分子伴侣 HSP70 中的隐蔽二级结合位点并对其进行表征。
Molecules. 2022 Jan 26;27(3):817. doi: 10.3390/molecules27030817.
9
Highly Antiproliferative Latonduine and Indolo[2,3-]quinoline Derivatives: Complex Formation with Copper(II) Markedly Changes the Kinase Inhibitory Profile.高度抗增殖的拉顿丁和吲[2,3-]喹啉衍生物:与铜(II)形成配合物显著改变激酶抑制特性。
J Med Chem. 2022 Feb 10;65(3):2238-2261. doi: 10.1021/acs.jmedchem.1c01740. Epub 2022 Feb 1.
10
New Deoxycholic Acid Derived Tyrosyl-DNA Phosphodiesterase 1 Inhibitors Also Inhibit Tyrosyl-DNA Phosphodiesterase 2.新型去氧胆酸衍生酪氨酸-DNA 磷酸二酯酶 1 抑制剂也抑制酪氨酸-DNA 磷酸二酯酶 2。
Molecules. 2021 Dec 23;27(1):72. doi: 10.3390/molecules27010072.